We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTRK
12101
PUT
DELISTED
Ontrak
OTRK
$107K ﹤0.01%
526
-117
-18% -$31.9K
PPBT
12102
CALL
Purple Biotech
PPBT
$2.52M
$107K ﹤0.01%
135
-1
-0.7% -$645
PTPI
12103
DELISTED
Petros Pharmaceuticals
PTPI
$107K ﹤0.01%
+276
New +$116K
REE
12104
DELISTED
REE Automotive
REE
$107K ﹤0.01%
+1,874
New +$191K
RES icon
12105
PUT
RPC Inc
RES
$1.4B
$107K ﹤0.01%
+10,000
New +$79.8K
IRD
12106
CALL
Opus Genetics
IRD
$323M
$107K ﹤0.01%
33,000
+12,000
+57% +$41.1K
LUMO
12107
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$107K ﹤0.01%
+11,339
New +$101K
OSG
12108
DELISTED
Overseas Shipholding Group Inc.
OSG
$107K ﹤0.01%
51,403
+22,307
+77% +$43.3K
GNOG
12109
PUT
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
$107K ﹤0.01%
15,100
-284,900
-95% -$2.2M
ARKO icon
12110
CALL
ARKO Corp
ARKO
$495M
$106K ﹤0.01%
11,700
-25,400
-68% -$214K
CNDT icon
12111
PUT
Conduent
CNDT
$245M
$106K ﹤0.01%
20,600
-43,400
-68% -$213K
INCR
12112
Intercure
INCR
$56.9M
$106K ﹤0.01%
15,063
-16,678
-53% -$110K
HTT
12113
CALL
High Templar Tech Ltd
HTT
$388M
$106K ﹤0.01%
90,200
-117,600
-57% -$113K
SLI
12114
Standard Lithium
SLI
$603M
$106K ﹤0.01%
12,011
+1,425
+13% +$9.65K
ARBGU
12115
DELISTED
Aequi Acquisition Corp Unit
ARBGU
$106K ﹤0.01%
10,740
APPH
12116
DELISTED
AppHarvest, Inc. Common Stock
APPH
$106K ﹤0.01%
19,667
-30,269
-61% -$125K
LEGAW
12117
DELISTED
Lead Edge Growth Opportunities, Ltd Warrant
LEGAW
$106K ﹤0.01%
313,130
TCACU
12118
DELISTED
Tuatara Capital Acquisition Corporation Unit
TCACU
$106K ﹤0.01%
10,447
-300
-3% -$3.02K
DCGO icon
12119
PUT
DocGo
DCGO
$57.4M
$105K ﹤0.01%
+11,400
New +$85.8K
VYGR icon
12120
PUT
Voyager Therapeutics
VYGR
$197M
$105K ﹤0.01%
13,800
-11,200
-45% -$50K
TRVN
12121
CALL
DELISTED
Trevena, Inc.
TRVN
$105K ﹤0.01%
305
-445
-59% -$140K
SURF
12122
PUT
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$105K ﹤0.01%
35,800
-12,600
-26% -$44.2K
MLACU
12123
DELISTED
Malacca Straits Acquisition Company Limited Units
MLACU
$105K ﹤0.01%
10,377
EVFM
12124
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$105K ﹤0.01%
20,598
+18,733
+1,004% +$118K
BKD icon
12125
PUT
Brookdale Senior Living
BKD
$3B
$104K ﹤0.01%
14,800
-16,000
-52% -$97.7K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.